Service alert

When to Test and When to Reject a Specimen

11/19/2026
Podcast

November 19, 2026

Clinical Pathology Improvement Program (CPIP) | College of American Pathologists

Self-care Can’t Fix the Problems Plaguing Doctors | STAT

The ‘Pathogen Hunters’ track microbes around the world. But are their data real? | Science | AAAS

Evidence of Widespread Sequencing Errors in Global Avian Influenza Study | Nature Communications

Absolute Risk of Progression to Cognitive Impairment Based on Plasma Phosphorylated Tau 217, Age, Sex, and APOE ε4 | Dementia and Cognitive Impairment | JAMA Neurology | JAMA Network

Elizabeth McMahon

When to test microbiology specimens and when to reject them. Plus, forget candles and bubble baths as prescriptions for burnout. A former surgeon on why institutions need to look inward. Welcome to CAP News for Thursday, November 19th. I'm Elizabeth McMahon of the College of American Pathologists. Here's what's making news in pathology and laboratory medicine. When a specimen arrives in the lab, the path to a diagnosis can stop cold if it was improperly collected or transported. Those steps are crucial to accurate results, says Dr. Christi Wojewoda, Director of the Clinical Microbiology Laboratory at the University of Vermont Medical Center. She's the author of this month's Clinical Pathology Improvement Program course on when to test and when to reject microbiology specimens. The CPIP course reviews common and controversial scenarios that pathologists encounter in the microbiology lab. One example is testing for the common C. diff bacterial infection.

Dr. Christi Wojewoda

So if your patient doesn't have diarrhea, if the stool isn't diarrhea, then we can't test it because we could be detecting colonization rather than true infection. I've kind of tried to give some tips and tricks into things that we have run into in my laboratory and then some possible solutions. So starting with educating the groups that are collecting the samples.

Elizabeth McMahon

Unlike urine or stool samples, irretrievable samples, for example, those obtained during surgery, cannot be collected again. They too can occasionally be collected or transported inappropriately. The CPIP course will also cover some of those difficult scenarios. Rejecting samples can ruffle feathers, but it serves a greater purpose, Dr. Wojewoda says.

Dr. Christi Wojewoda

I'm hoping to show that no, we're really doing the patient and the provider a disservice by testing a suboptimal specimen. And if it's really better for the patient if we request another sample so that we can give the best diagnosis, not just any diagnosis.

Elizabeth McMahon

Bubble baths, aromatherapy, long walks. Do these recommendations for burned-out doctors really work? Not by a long shot, according to a new piece in Stat News. Dr. Francis Mei Hardin, a former ear, nose, and throat surgeon, says institutions push for self-care to address burnout because it's cheaper than fixing the system. CAP Wellness Project Lead Dr. Marisa Saint Martin agrees. Institutions often make a mistake by tackling burnout on a case-by-case basis, She says.

Dr. Marisa Saint Martin

We see most of the uh strategies presented in in different institutions that is about that person. You had to sleep better, you had to eat better, you had to, you know, do yoga, do meditation, and then the person that is burnout is feeling even more burned out because now they have a super long list of other things that they need to do to get better.

Elizabeth McMahon

Dr. Mei Hardin says research is clear about what works: more flex time, additional vacation days, compensation for hours worked, removing the invisible admin burden, and agency overscheduling. Quote, what actually works is boring and it's expensive. It's a labor problem that was conveniently rebranded as a mental health problem, mainly because candles, paid for by the physician, are cheaper than hiring more staff. An article this month in the journal Nature Communications has cast doubt on flu virus findings from a controversial group that calls itself the Pathogen Hunters. Led by a scientist at Yamagata University in Japan, the Pathogen Hunters published a 2025 paper in Nature Communications claiming that the genetic sequences of some flu viruses found in guano in Africa, the Middle East, and other regions was identical to strains found years earlier. The claim raised immediate skepticism because flu virus RNA constantly changes. Science News has examined Pathogen Hunter's track record, reporting that over the past four years, the Pathogen Hunters published dozens of studies based on more than 60,000 samples that they claim they collected in 38 countries. Some of the pathogen hunters' publications were retracted, while others received substantive corrections. A blood biomarker called PTau 217 that's associated with Alzheimer's disease may help estimate a healthy person's risk of developing cognitive impairment or dementia in the future. A team at Mayo Clinic, led by pathology researcher Dr. Alicia Algeciras Schimnich, analyzed more than 2,000 cognitively unimpaired people ages 60 to 90 who were part of aging and neuroimaging studies. Participants had PTAW 217 blood measurements, genetic testing, and repeated cognitive assessments. Older aged patients with higher levels of the biomarker PTAU 217 had a greater risk of developing impairment or dementia. The findings, published in JAMA Neurology, build on research into therapies that could prevent or delay symptoms of cognitive decline years before they occur. That's all for today. Be sure to check the show notes for more information on today's stories. Got a story you'd like to hear on the podcast? Write to us at stories at CAP.org. We're back at 5 AM Eastern for another episode of CAP News. I'm Elizabeth McMahon. Have a great day.